CR20170601A - Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina - Google Patents

Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina

Info

Publication number
CR20170601A
CR20170601A CR20170601A CR20170601A CR20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A
Authority
CR
Costa Rica
Prior art keywords
emtricitabina
pharmaceutical formulations
include tenofovir
tenofovir
pharmaceutically acceptable
Prior art date
Application number
CR20170601A
Other languages
English (en)
Inventor
Joanna M Koziara
Scott Mccallister
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Priority claimed from PCT/US2016/040158 external-priority patent/WO2017004244A1/en
Publication of CR20170601A publication Critical patent/CR20170601A/es

Links

Abstract

La invención proporciona una forma de dosificación oral sólida que comprende alafenamida de tenofovir o una sal farmacéuticamente aceptable de la misma, y emtricitabina o una sal farmacéuticamente aceptable de la misma.
CR20170601A 2015-06-30 2016-06-29 Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina CR20170601A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562187113P 2015-06-30 2015-06-30
US201662298373P 2016-02-22 2016-02-22
US201662317286P 2016-04-01 2016-04-01
PCT/US2016/040158 WO2017004244A1 (en) 2015-06-30 2016-06-29 Pharmaceutical formulations comprising tenofovir and emtricitabine

Publications (1)

Publication Number Publication Date
CR20170601A true CR20170601A (es) 2018-02-28

Family

ID=61730529

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20170601A CR20170601A (es) 2015-06-30 2016-06-29 Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina

Country Status (1)

Country Link
CR (1) CR20170601A (es)

Similar Documents

Publication Publication Date Title
CO2017013293A2 (es) Formulaciones farmacéuticas que comprenden tenofovir y emtricitabina
IL258464A (en) Pharmaceutical compositions for oral administration of peptide drugs
IL251462A0 (en) Pharmaceutical formulations for oral administration of peptide or protein drugs
MX2017016802A (es) Formulaciones farmaceuticas.
HUP1700253A1 (hu) Szilárd orális gyógyszerkészítmények
MA46867A (fr) Formulations pharmaceutiques
PH12016501841A1 (en) Immunosuppressant formulation
ZA202006570B (en) Pharmaceutical formulations
MA55015A (fr) Formulations pharmaceutiques
MX2018005358A (es) Comprimido de dosis alta que contiene mesalazina optimizado.
AR108233A1 (es) Composiciones farmacéuticas orales de nicotinamida
IL282343A (en) soluble medicinal compounds
GB2591396B (en) Pharmaceutical suspension for oral dosage
PL3326619T3 (pl) Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę
CR20170601A (es) Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina
SG11202010792TA (en) Improved pharmaceutical formulations
EP3697393A4 (en) PHARMACEUTICAL DOSAGE FORMS
JOP20170198A1 (ar) صيغ صيدلية تشتمل على تينوفوفير و إيمترايسيتابين
CY1123966T1 (el) Διαδικασια για την παρασκευη νατριουχου εποπροστενολης ενισχυμενης σταθεροτητας
EP3675842A4 (en) PHARMACEUTICAL DOSAGE FORMS
TR201721065A2 (tr) Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar
ZA201804275B (en) Oral pharmaceutical composition comprising taste-masked n-acetylcysteine
CY1119636T1 (el) Φαρμακευτικο παρασκευασμα με βαση διοσμεκτιτη
TH1501007612A (th) อมอร์ฟัสลีเทอร์โมเวียร์และสูตรผสมของแข็งทางเภสัชกรรมของมันสำหรับให้เข้าทางปาก